Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...
A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible ...
Walmart is expanding its insurance coverage to offer advanced cancer treatment for employees and their dependents at the Mayo ...
The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with resectable NSCLC.
Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...
The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients ...
About three months from opening, the the new Nebraska Medicine cancer facility in Kearney now has a name: Nebraska Medicine ...
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
A supplemental new drug application seeking expanded indication for darolutamide combined with androgen deprivation therapy ...
Bayer Submits SNDA For Expanded Use Of NUBEQA In Metastatic Hormone-Sensitive Prostate Cancer To FDA
NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC). Indices Commodities ...
Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback